The global Single-Use Bioreactor Market is estimated to be valued at US$1,001.0 Mn in 2021 and is projected to reach US$1,889.8 Mn by 2028, witnessing a CAGR of 9.1% over the forecast period. This market research report focuses on the increasing adoption of single-use bioreactors in various industries due to their efficiency and cost-effectiveness. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors, such as reduced contamination risk, shorter turnaround times, flexibility in production, and lower capital investments, making them highly desirable in the market.
Market Overview: Single-use bioreactors are increasingly being used in the biopharmaceutical and biotechnology industries. These bioreactors are ideal for small-scale production and research and development activities. They eliminate the need for cleaning, sterilization, and validation processes associated with traditional bioreactors. The growing demand for biologics, advancements in single-use technologies, and the need for reducing manufacturing costs are driving the growth of the single-use bioreactor market. Market Key Trends: One prominent trend observed in the single-use bioreactor market is the increasing adoption of single-use stirrer bioreactors. These bioreactors offer advantages such as ease of use, scalability, and reduced contamination risk. They are widely used in the production of monoclonal antibodies, vaccines, stem cells, and gene therapy products. The single-use stirrer bioreactors ensure efficient culture processes, improved productivity, and lower operating costs. Their flexibility and cost-effectiveness make them an attractive choice for biopharmaceutical manufacturers. Segment Analysis: The single-use bioreactor market can be segmented based on type, application, end-user, and region. In terms of type, the single-use bioreactor market can be divided into wave-induced bioreactors, stirred-tank bioreactors, and bubble-induced bioreactors. Among these, the stirred-tank bioreactors segment dominates the market. Stirred-tank bioreactors are widely used due to their ability to handle high biomass, scalability, and compatibility with traditional fermentation processes. They offer advantages such as robustness, flexibility, and ease of use, which make them the preferred choice in biopharmaceutical manufacturing. Based on application, the single-use bioreactor market can be categorized into research & development, vaccine production, therapeutic protein production, and other applications. Therapeutic protein production is the dominant segment as the demand for biologic drugs, such as monoclonal antibodies and recombinant proteins, continues to grow. The production of therapeutic proteins requires efficient bioreactors that can accommodate high cell densities and achieve high product yields. On the basis of end-user, the single-use bioreactor market can be segmented into biopharmaceutical manufacturers, contract manufacturing organizations (CMOs), and research & academic institutions. The biopharmaceutical manufacturers segment holds the largest market share. This can be attributed to the increasing demand for biologic drugs and the adoption of single-use bioreactors for the efficient production of these drugs. Key Takeaways: The global Single-Use Bioreactor Market Share is expected to witness high growth, exhibiting a CAGR of 15.6% between 2022 and 2028. This growth can be attributed to several factors. Firstly, the increasing prevalence of chronic diseases and the growing demand for biologic drugs are driving the adoption of single-use bioreactors. These bioreactors offer advantages such as reduced contamination risks, shorter turnaround times, and lower capital investments compared to traditional stainless-steel bioreactors. Moreover, the increasing focus on personalized medicine and the development of biosimilars further contribute to the market growth. In terms of regional analysis, North America dominates the single-use bioreactor market. The region has a strong presence of biopharmaceutical manufacturers and CMOs, as well as a favorable regulatory environment for biologic drug manufacturing. The Asia Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as the growing healthcare infrastructure, increasing investments in biopharmaceutical manufacturing, and the presence of a large patient pool contribute to market growth in this region. Key players operating in the single-use bioreactor market include Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. These companies focus on product launches Read More, https://www.insightprobing.com/single-use-bioreactor-market-trends-size-and-share-analysis/
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2024
Categories
All
|